文章摘要

参考文献/References

［1］张继业.他汀类药物的非降脂作用［J］. 心脏杂志，2001，13（1）：52-53.

[2］Sven W, Ulrich L, Kirsten M, et al. Cellular antioxidant effects of atorvatatin in vitro and in vivo［J］. Aterioscler Thromb Vasc Biol， 2002, 22: 300-305.

［3］刘宇宏，曾秋棠，毛晓波，等. 氟伐他汀防治缺血性心脏病心衰及其抗氧化应激作用的实验研究［J］. 心脏杂志，2005，17(1)：21-28.

［4］Seljeflot I, Tonsatd S, Hjermann I, et al. Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease［J］. Atherosclerosis, 2002, 162(1): 179-185.

［5］Walter DH, Ritting K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrowderived endothelial progenitor cells ［J］. Circulation, 2002, 105(25): 3017-3024.

［6］Kishi T, Hirooka Y, Mukai Y, et al. Atorvastatin causes depressor and sympathoinhibitory effects with upregulation of nitric oxide synthase in strokeprone spontaneously hypertensive rats ［J］. J Hypertens, 2003, 21(2): 379-386.

［7］季彦，戚文航，高平进，等.辛伐他汀对兔动脉粥样硬化髂动脉TIMP1表达的影响［J］.中华心血管病杂志，2002，30（8）：500-503.

［8］Luan Z, Chase AJ, Newby AC. statins inhibit secretion of metalloproteinase1、-2、-3 and –9 from vascular smooth muscle cells and macrophages［J］. Arterioscler Thromb Vasc Biol, 2003, 23(5): 769-775.

［9］Gross CM, Gerbaulet S, Quensel S,et al. Agiotensin II type I receptor expression in human coronary arteries with viriable degrees of atheriosclerosis［J］. Basic Res Cardiol, 2002, 97(4): 327-333.

［10］王安才，成蓓，谢小竞，等.阿托伐他汀对自发性高血压大鼠心室重构的影响［J］.中国临床药理学与治疗学杂志，2004，9（8）：880-884.

［11］Matsuno H, Takei M, Hayashi H, et al. Simvastatin enhance the regeneration of endothelial cells via VEGF secretion in injured arteties［J］. J Cardiovasc Pharmacol， 2004, 43(3): 333-340.

［12］Takenaka M, Hirade K, Tanabe K, et al. Simvastatin stimulates VEGF release via P44/P42 MAP kinase in vascular smooth muscle cells［J］. Biochem Biophys Res Commun， 2003, 301(1): 198-203.

［13］Albert HF, Dulak J, Frick M, et al. Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease［J］. J Am Coll Cardiol， 2002, 39(12): 1951-1955.

［14］张路，吴宗贵，黄越承，等.辛伐他汀对人脐静脉内皮细胞血管内皮生长因子表达的影响［J］. 中国动脉硬化杂志，2004，12（4）：423-426.

［15］Saijonmaa O, Nyman T, Stewen P, et al. Atorvastatin completely inhibits VEGFinduced ACE upregulation in human endothelial cells［J］. Am J Physiol Heart Circ Physiol， 2004, 286(6): H2096-H2102.

［16］黄芸，戴闺柱，冯宗忱，等. 高脂血症患者低密度脂蛋白氧化易感性及调脂药物干预的影响［J］.中华心血管病杂志，2002，30（9）：542-544.

我们的网站为什么显示成这样？

他汀类药物对血管重构的干预机制(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics